We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Green Tea Acts Against Breast Cancer

By Biotechdaily staff writers
Posted on 31 Mar 2005
Researchers studying the purported anticancer properties of green tea have found that the tea polyphenol (–)-epigallocatechin-3-gallate (EGCG) prevented the development of breast cancer and its metastasis in a mouse model.

Investigators at the University of Alabama (Birmingham, USA) worked with highly metastatic mouse mammary carcinoma 4T1 cells. More...
Treatment of 4T1 cells growing in tissue culture with EGCG resulted in inhibition of cell proliferation and the induction of apoptosis in a fashion that was dependent on size of the dose and length of time of the exposure. When EGCG was administered in drinking water to mice infected with 4T1 cancer cells, reduction of tumor growth resulted. Metastasis of tumor cells to lungs was inhibited, and survival period of animals was increased. These findings were published in the March 1, 2005, issue of Clinical Cancer Research.

Results of the current study add weight to the likelihood that green tea has beneficial anti-cancer effects. Senior author Dr. Santosh K. Katiyar, a researcher in the dermatology department at the University of Alabama said, "We discovered in test tube and in mouse studies that tea polyphenols have the ability to inhibit the growth of breast tumor cells and slow down their metastasis to other organs.”




Related Links:
University of Alabama

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automatic CLIA Analyzer
Shine i6000
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.